Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 64075

the quality of care and the quality of life 

at the end of life. Topics of resulting 

NIH initiatives have included the 

clinical management of symptoms at the 

end of life; patterns of communication 

among patients, families, and providers; 

ethics and health care decision making; 

caregiver support; the context of care 

delivery; complementary and alternative 

medicine at the end of life; dying 

children and their families; and 

informal care-giving. This conference 

will examine the results of these many 

efforts and evaluate the current state of 

the science. 

During the first day-and-a-half of the 

conference, experts will present the 

latest research findings on end-of-life 

care to an independent panel. After 

weighing all of the scientific evidence, 

the panel will draft a statement, 

addressing the following key questions:

• What defines the transition to end of 

life? 

• What outcome variables are important 

indicators of the quality of the end of 

life experience for the dying person 

and for the surviving loved ones? 

• What patient, family, and health care 

system factors are associated with 

improved or worsened outcomes? 

• What processes and interventions are 

associated with improved or 

worsened outcomes? 

• What are future research directions 

for improving end-of-life care?

On the final day of the conference, the 

panel chairperson will read the draft 

statement to the conference audience 

and invite comments and questions. A 

press conference will follow to allow 

the panel and chairperson to respond to 

questions from the media. 

The primary sponsors of this meeting 

are the National Institute of Nursing 

Research and the NIH Office of Medical 

Applications of Research. 

Advance information about the 

conference and conference registration 

materials may be obtained from 

American Institutes for Research of 

Silver Spring, Maryland, by calling 888–

644–2667, or by sending e-mail to 

endoflifecare@air.org. American 

Institutes for Research’s mailing address 

is 10720 Columbia Pike, Silver Spring, 

MD, 20901. Registration information is 

also available on the NIH Consensus 

Development Program Web site at http:/

/consensus.nih.gov.

Please Note: The NIH has recently 

instituted new security measures to ensure 

the safety of NIH employees and property. 

All visitors must be prepared to show a photo 

ID upon request. Visitors may be required to 

pass through a metal detector and have bags, 

backpacks, or purses inspected or x-rayed as 

they enter NIH buildings. For more 

information about the new security measures 

at NIH, please visit the Web site at http://

www.nih.gov/about/visitorssecurity.htm.

Dated: October 22, 2004. 

Raynard S. Kington, 

Deputy Director, National Institutes of Health.

[FR Doc. 04–24479 Filed 11–2–04; 8:45 am] 

BILLING CODE 4410–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. appendix 2), notice 

is hereby given of a meeting of the Sleep 

Disorders Research Advisory Board. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: Sleep Disorders 

Research Advisory Board. 

Date: December 7, 2004. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To discus sleep research and 

education priorities and programs. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. 

Contact Person: Carl E. Hunt, MD, Director, 

National Center of Sleep Disorders Research, 

National Heart, Lung, and Blood Institute, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 10138, Bethesda, MD 20892, 

301/435–0199. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the ‘‘Contact Person’’ listed 

on this notice. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s Home page: http://

www.nhlbi.nih.gov/meetings/index.htm,

where an agenda and any additional 

information for the meeting will be posted 

when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS.)

Dated: October 27, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24485 Filed 11–2–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such a patentable material, and 

personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Fatty Acids and 

Food Intake Regulation. 

Date: November 30, 2004. 

Time: 5 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892, (Telephone 

Conference Call). 

Contact Person: Maria E. Davila-Bloom, 

PhD, Scientific Review Administrator, 

Review Branch, DEA, NIDDK, National 

Institutes of Health, Room 758, 6707 

Democracy Boulevard, Bethesda, MD 20892–

5452, (301) 594–7637, davilabloomm@extra.niddk.nih.gov.

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel, Sepsis and Renal 

Failure. 

Date: December 15, 2004. 

Time: 9 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Michele L. Barnard, PhD, 

Scientific Review Administrator, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 753, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–8898, barnardm@extra.niddk.nih.gov.

64076 Federal Register / Vol. 69, No. 212 / Wednesday, November 3, 2004 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS)

Dated: October 27, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–24482 Filed 11–2–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neurovirology. 

Date: November 11, 2004. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Robert Freund, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3200, 

MSC 7848, Bethesda, MD 20892, (301) 435–

1050, freundr@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clinical 

Neurophysiology, Devices and 

Neuroprosthetics/Brain Disorders and 

Clinical Neuroscience/SBIR. 

Date: November 15–16, 2004. 

Time: 8:30 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave., Bethesda, MD 20814. 

Contact Person: Vinod Charles, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5196 

MSC 7846, Bethesda, MD 20892, (301) 435–

0902, charlesvi@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 ONC 

J 04: Tumor Biology of Melanoma. 

Date: November 15, 2004. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Martin L. Padarathsingh, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6212, 

MSC 7804, Bethesda, MD 20892, (301) 435–

1717, padaratm@csr.nih.gov.

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Cardiovascular Sciences Small Business 

Activities. 

Date: November 17–18, 2004.

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: Lawrence E. Boerboom, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5156, 

MSC 7814, Bethesda, MD 20892, (301) 435–

8367, boerboom@nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Mechanism 

of Tumorigenesis. 

Date: November 17, 2004. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Zhiqiang Zou, MD, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6190, 

MSC 7804, Bethesda, MD 20892, (301) 451–

0132, zouzhiq@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Social Sciences and Population 

Studies. 

Date: November 17, 2004. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: William N. Elwood, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3162, 

MSC 7770, Bethesda, MD 20892, (301) 435–

1503, elwoodwi@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 IFCN 

E (03) Sensory Integration. 

Date: November 17, 2004. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Bernard F. Driscoll, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, (301) 435–

1242, driscolb@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, System 

Lupus Erythematosus (SLE). 

Date: November 17, 2004. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Cathleen L. Cooper, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4208, 

MSC 7812, Bethesda, MD 20892, (301) 435–

3566, cooperc@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Antibiotic 

Resistance. 

Date: November 17, 2004. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Diane L. Stassi, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3202, 

MSC 7808, Bethesda, MD 20892, (301) 435–

2514, stassid@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Transplant 

Immunology. 

Date: November 17, 2004. 

Time: 3 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Calbert A. Laing, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4210, 

MSC 7812, Bethesda, MD 20892, (301) 435–

1221, laingc@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Coxiella. 

Date: November 17, 2004. 

Time: 3 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications.